MBS for weight loss shows greater long-term benefits than GLP-1 medicines
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo metabolic and bariatric surgery (MBS)...
top of page
Headlines
MBS for weight loss shows greater long-term benefits than GLP-1 medicines
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo metabolic and bariatric surgery (MBS)...
Research
Journal watch 24/9/2025
Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Distribution of fat could influence cancer risk but varies by cancer type
How fat is distributed in people's bodies could make a difference to their risk of certain cancers, according to research led by the...
Pfizer to acquire Metsera and its next-generation obesity portfolio
Pfizer and Metsera have entered into a definitive agreement under which Pfizer will acquire Metsera, a clinical-stage biopharmaceutical...
Severe obesity associated with reduced prevalence of cancer screenings
In a recent cross-sectional study, researchers from Pennington Biomedical Research Center found that severe obesity is associated with a...
The future of obesity management – quintuple and other super polyagonists
In a session at this year’s Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria, researchers...
First commercial patient treated with Morphic Medical’s RESET device
Morphic Medical has announced that the first commercial patient has been treated with RESET, the company’s therapy designed to target the...
ASC47 in combination with semaglutide has 56.2% reduction in body semaglutide monotherapy
Ascletis Pharma’s ASC47, a muscle-preserving weight loss drug candidate, in combination with semaglutide demonstrated up to 56.2% greater...
Metamaterial could transform future of implantable and ingestible medical devices
Researchers led by Rice University's Yong Lin Kong have developed a soft but strong metamaterial that can be controlled remotely to...
Some plastic surgeons are treating obesity as a cosmetic issue rather than a chronic disease
Researchers from the College of Public Health, Temple University, Philadelphia, PA, have warned how some plastic surgeons are promoting...
MBS achieves greater weight loss with lower ongoing cost vs GLP-1s
Metabolic bariatric surgery (MBS) achieves greater weight loss and lower ongoing cost compared to the glucagon-like peptide-1 receptor...
Journal watch 17/9/2025
Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Lilly’s oral GLP-1 orforglipron shows meaningful weight loss and cardiometabolic improvements
Results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron, an investigational oral glucagon-like...
Industry
All caught up?
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Events
3rd Annual International Symposium on Magnetic Gastrointestinal and Colon Surgery
Tweets
bottom of page